Date | Revenue Per Share | Dividend Per Share | Free Cash Flow Per Share | Return on Assets (ROA) |
---|
CEO | Mr. Rui Kuan Fang |
IPO Date | Sept. 2, 2016 |
Location | China |
Headquarters | No. 199, 15th Avenue |
Employees | 5,539 |
Sector | Health Care |
Industries |
Autobio Diagnostics Co., Ltd. engages in the research and development, production, and distribution of clinical diagnostic products. It develops immunoassay, biochemistry, microbiology, and IVD reagents; and instruments, such as automation and semi-automation systems, as well as medical laboratory solutions. The company's immunoassay products AutoLumo A2000 Plus, an automatic Chemiluminescence immunoassay analyzer; automatic microplate chemiluminescent enzyme immunoassay; and LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Its microbiology products comprise automated blood culture systems; blood culture bottles; AUTOMIC strips; and mycoplasma IES. The company was formerly known as Lifeclone Diagnostics Co., Ltd. and changed its name to Autobio Diagnostics Co., Ltd. in 2003. Autobio Diagnostics Co., Ltd. was founded in 1998 and is based in Zhengzhou, China. Autobio Diagnostics Co., Ltd. is a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Past 5 years
USD 3.92
USD 3.33
USD 5.73
USD 8.60
USD 3.54
StockViz Staff
January 15, 2025
Any question? Send us an email